Intra-Cellular Therapies, Inc.·4

Feb 26, 6:01 PM ET

MARCUS JOEL S 4

4 · Intra-Cellular Therapies, Inc. · Filed Feb 26, 2025

Insider Transaction Report

Form 4
Period: 2025-02-24
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-24$63.79/sh+7,009$447,10448,238 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-02-247,0090 total
    Exercise: $63.79Exp: 2033-06-22Common Stock (7,009 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    10,000
Footnotes (2)
  • [F1]Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
  • [F2]All shares underlying this option have vested.

Documents

2 files